Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)	Digestive System Diseases, Digestive System Neoplasms, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm	Recruiting	Phase 3	2026-08-10		NCT05534087

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Seoul National University Hospital	277

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ajou University Hospital	Suwon	South Korea	31
Asan Medical Center	Seoul	South Korea	131
Chonnam National University Hwasun Hospital	Hwasun	South Korea	12
Chung-Ang University Hospital	Seoul	South Korea	21
Dong-A University Hospital	Busan	South Korea	20
Korea University Guro Hospital	Seoul	South Korea	57
Kyungpook National University Chilgok hospital	Daegu	South Korea	19
National Cancer Center	Goyang	South Korea	14
Samsung Medical Center	Seoul	South Korea	170
Seoul National University Bundang Hospital	Seongnam	South Korea	42
Seoul National University Hospital	Seoul	South Korea	183
Severance Hospital	Seoul	South Korea	62
SMG-SNU Boramae Medical Center	Seoul	South Korea	5